Literature DB >> 23705046

Cerebrotendinous xanthomatosis--the spectrum of imaging findings.

Arunachalam Pudhiavan1, Alka Agrawal, Sangit Chaudhari, Anil Shukla.   

Abstract

Cerebrotendinous xanthomatosis (CTX), also known as Van Bogaert-Scherer-Epstein disease is a rare autosomal recessive genetic disorder of the lipid metabolism. To date, there are less than 300 cases reported worldwide. We present a case of a 30 year old male who presented with mental retardation and swelling of ankles, with the a spectrum of CTX imaging findings. Imaging studies were performed which included plain X-ray, Ultrasound(US) and Magnetic Resonance Imaging(MRI) of both the brain and ankles. These pointed towards the diagnosis of CTX with the entire spectrum of findings which was confirmed with biopsy and laboratory findings. CTX is a potentially treatable condition with replacement therapy, and hence early diagnosis before neurological deterioration is important. This is aided by the imaging findings which are conclusive forte diagnosis of CTX.

Entities:  

Keywords:  CTX; CYP27A1; Cerebrotendinous xanthomatosis; Chenodeoxycholic acid; Cholestanol

Mesh:

Year:  2013        PMID: 23705046      PMCID: PMC3661428          DOI: 10.3941/jrcr.v7i4.1338

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  12 in total

Review 1.  Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene.

Authors:  G N Gallus; M T Dotti; A Federico
Journal:  Neurol Sci       Date:  2006-06       Impact factor: 3.307

2.  Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis.

Authors:  A Verrips; G J Nijeholt; F Barkhof; B G Van Engelen; P Wesseling; J A Luyten; R A Wevers; J Stam; J H Wokke; L P van den Heuvel; A Keyser; F J Gabreëls
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

3.  Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings.

Authors:  F Barkhof; A Verrips; P Wesseling; M S van Der Knaap; B G van Engelen; F J Gabreëls; A Keyser; R A Wevers; J Valk
Journal:  Radiology       Date:  2000-12       Impact factor: 11.105

4.  Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.

Authors:  G Salen; V Berginer; V Shore; I Horak; E Horak; G S Tint; S Shefer
Journal:  N Engl J Med       Date:  1987-05-14       Impact factor: 91.245

5.  Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.

Authors:  M Kuriyama; Y Tokimura; J Fujiyama; Y Utatsu; M Osame
Journal:  J Neurol Sci       Date:  1994-08       Impact factor: 3.181

6.  Magnetic resonance imaging in cerebrotendinous xanthomatosis: a prospective clinical and neuroradiological study.

Authors:  V M Berginer; J Berginer; A D Korczyn; R Tadmor
Journal:  J Neurol Sci       Date:  1994-03       Impact factor: 3.181

Review 7.  Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy.

Authors:  Antonio Federico; Maria Teresa Dotti
Journal:  J Child Neurol       Date:  2003-09       Impact factor: 1.987

8.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.

Authors:  V M Berginer; G Salen; S Shefer
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

Review 9.  Cerebrotendinous xanthomatosis (van Bogaert-Scherer-Epstein disease): CT and MR findings.

Authors:  M T Dotti; A Federico; E Signorini; N Caputo; C Venturi; G Filosomi; G C Guazzi
Journal:  AJNR Am J Neuroradiol       Date:  1994-10       Impact factor: 3.825

Review 10.  Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.

Authors:  Mohammed H Moghadasian
Journal:  Clin Invest Med       Date:  2004-02       Impact factor: 0.825

View more
  7 in total

Review 1.  Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.

Authors:  Janice C Wong; Kailey Walsh; Douglas Hayden; Florian S Eichler
Journal:  J Inherit Metab Dis       Date:  2018-02-26       Impact factor: 4.982

2.  Cerebrotendinous xanthomatosis - A case report.

Authors:  Arshed Hussain Parry; Abdul Haseeb Wani; Muiez Bashir; Tariq A Gojwari
Journal:  Indian J Radiol Imaging       Date:  2019-10-30

3.  Chinese patient with cerebrotendinous xanthomatosis confirmed by genetic testing: A case report and literature review.

Authors:  Lan-Xiao Cao; Mi Yang; Ying Liu; Wen-Ying Long; Guo-Hua Zhao
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

Review 4.  The clinical and imaging features of cerebrotendinous xanthomatosis: A case report and review of the literature.

Authors:  Chi Ma; Yan-De Ren; Jia-Chen Wang; Cheng-Jian Wang; Ji-Ping Zhao; Tong Zhou; Hua-Wei Su
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

5.  Xanthomatosis in bilateral hands mimicking rheumatoid arthritis: A case report.

Authors:  Dan Li; Longfei You; Songqing Fan; Lihua Tan
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

6.  Achilles swelling and ataxia in an adolescent: A case report of cerebrotendinous xanthomatosis.

Authors:  Hind Sahli; Jihane El Mandour; Jihad Boularab; Issam En-Nafaa; Jamal El Fenni; Aziz Hommadi
Journal:  Radiol Case Rep       Date:  2022-01-13

7.  Imaging of Dentate Nucleus Pathologies: A Case Series.

Authors:  Usha Chowdary M K; Naveen Prasad S V; Satish Gudla; Vengamma Bhuma
Journal:  J Neurosci Rural Pract       Date:  2022-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.